Search Results
Inserm U1016, CNRS UMR 8104, Institut Cochin, Université Paris Descartes-Université de Paris, Paris, France
Search for other papers by Chiara Villa in
Google Scholar
PubMed
Department of Neurosurgery, Hôpital Universitaire Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
Search for other papers by Bertrand Baussart in
Google Scholar
PubMed
Department of Endocrinology, Center for Rare Adrenal Diseases, Hôpital Cochin APHP, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Lyon 1 University, Villeurbanne, France
Inserm U1052, CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
WHO 2004 ENDO4 WHO 2017 CNS5 WHO 2021 ENDO5 WHO 2022 Nomenclature Typical adenoma Adenoma ( Subtype ) Pituitary adenoma / pituitary neuroendocrine tumour (PitNET) ( Subtype ) Pituitary
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK
Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Search for other papers by Federico Roncaroli in
Google Scholar
PubMed
Search for other papers by Estelle Healy in
Google Scholar
PubMed
Search for other papers by Philip Weir in
Google Scholar
PubMed
Search for other papers by Madhu Basetti in
Google Scholar
PubMed
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Introduction Primary tumours of adenohypophyseal cells recently suggested to be redefined as pituitary neuroendocrine tumours (PitNETs) can rarely occur in association with paraganglioma (PGL) or phaeochromocytoma. These tumours may develop in
Search for other papers by Pedro Marques in
Google Scholar
PubMed
Search for other papers by Sayka Barry in
Google Scholar
PubMed
Search for other papers by Eivind Carlsen in
Google Scholar
PubMed
Search for other papers by David Collier in
Google Scholar
PubMed
Search for other papers by Amy Ronaldson in
Google Scholar
PubMed
Search for other papers by Sherine Awad in
Google Scholar
PubMed
Search for other papers by Neil Dorward in
Google Scholar
PubMed
Search for other papers by Joan Grieve in
Google Scholar
PubMed
Search for other papers by Nigel Mendoza in
Google Scholar
PubMed
Search for other papers by Samiul Muquit in
Google Scholar
PubMed
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Frances Balkwill in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Introduction The great majority of pituitary neuroendocrine tumours (PitNETs) are benign, although they can cause significant burden to patients due to mass effects, invasion and/or due to excessive or low hormone secretion ( Di Ieva et al
Search for other papers by Maria P Yavropoulou in
Google Scholar
PubMed
Search for other papers by Marina Tsoli in
Google Scholar
PubMed
Search for other papers by Konstantinos Barkas in
Google Scholar
PubMed
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
incidentally diagnosed during imaging investigations performed for unrelated purposes (pituitary incidentalomas, PIs) ( Scangas & Laws 2014 ). Recently, pituitary adenomas have been suggested to be renamed pituitary neuroendocrine tumours (pitNETs) ( Asa et al
Search for other papers by Judith Favier in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
Casey RT Hunter SJ & Korbonits M 2022 Succinate dehydrogenas e and MYC-associated factor X mutations in pituitary neuroendocrine tumours . Endocrine-Related Cancer 29 R157 – R172 . ( https://doi.org/10.1530/ERC-22-0157 ) Pacak K & Clifton
Endocrinology Department, ‘C.I. Parhon’ National Institute of Endocrinology, Bucharest, Romania
Search for other papers by Mirela Diana Ilie in
Google Scholar
PubMed
Pathology Department, Reference Center for Rare Pituitary Diseases HYPO, ‘Groupement Hospitalier Est’ Hospices Civils de Lyon, Bron, France
Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed
Neurosurgery Department, Reference Center for Rare Pituitary Diseases HYPO, ‘Groupement Hospitalier Est’ Hospices Civils de Lyon, Bron, France
Search for other papers by Emmanuel Jouanneau in
Google Scholar
PubMed
Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, ‘Groupement Hospitalier Est’ Hospices Civils de Lyon, Bron, France
Search for other papers by Gérald Raverot in
Google Scholar
PubMed
Chiloiro S Carlsen E Bianchi A Giampietro A Tartaglione T Bima C Bracaccia ME Lugli F Lauretti L , 2020 Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours . Endocrine 67 651 – 658 . ( https
Regional Centre for Endocrinology and Diabetes, Belfast Health and Social Care Trust, Belfast, UK
Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed
Search for other papers by Brian Herron in
Google Scholar
PubMed
Search for other papers by Stephen Cooke in
Google Scholar
PubMed
Search for other papers by Philip Weir in
Google Scholar
PubMed
Search for other papers by Jayna Elizabeth Smyth in
Google Scholar
PubMed
Search for other papers by Karen R Mullan in
Google Scholar
PubMed
Search for other papers by Estelle G Healy in
Google Scholar
PubMed
Search for other papers by Jane Evanson in
Google Scholar
PubMed
Search for other papers by Stephanie G Craig in
Google Scholar
PubMed
Department of Cellular Pathology, Belfast Health and Social Care Trust, Belfast, UK
Northern Ireland Biobank, Belfast Health and Social Care Trust, Belfast, UK
Search for other papers by Jacqueline A James in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Steven J Hunter in
Google Scholar
PubMed
Introduction Cushing’s disease (CD) is a rare condition of endogenous hypercortisolaemia resulting from an adrenocorticotrophin (ACTH)-secreting pituitary neuroendocrine tumour. Annual incidence of CD has been estimated at 1.2–1.8 cases per
Guys Richard Dimbleby Department of Cancer Research, Kings College London, London, UK
Endocard LTD, London, UK
Search for other papers by Dorota Dworakowska in
Google Scholar
PubMed
Centre for Endocrinology, William Harvey Institute, Barts and the London School of Medicine, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
World Health Organization (WHO) classification ( Osamura et al. 2017 a , b ), and even suggestions that we abandon the term ‘pituitary adenoma’ entirely in terms of these all being pituitary neuroendocrine tumours (PitNETs) ( Asa et al. 2017
Sorbonne University, UMR S 1127, Inserm U 1127, CNRS UMR 7225, ICM, Paris, France
Search for other papers by Francesca Branzoli in
Google Scholar
PubMed
Paris Cardiovascular Research Center (PARCC), Inserm, Paris, France
Search for other papers by Betty Salgues in
Google Scholar
PubMed
Search for other papers by Małgorzata Marjańska in
Google Scholar
PubMed
Search for other papers by Marie Laloi-Michelin in
Google Scholar
PubMed
Search for other papers by Philippe Herman in
Google Scholar
PubMed
Department of Endocrinology Diabetology, University Hospital Center of Reims, Reims, France
Department of Genetic, University Hospital Center of Reims, Reims, France
Search for other papers by Lauriane Le Collen in
Google Scholar
PubMed
CRESTIC EA 3804, University of Reims Champagne Ardenne, UFR Sciences Exactes et Naturelles, Moulin de La Housse, BP 1039, Reims, France
Search for other papers by Brigitte Delemer in
Google Scholar
PubMed
Search for other papers by Julien Riancho in
Google Scholar
PubMed
Search for other papers by Emmanuelle Kuhn in
Google Scholar
PubMed
Search for other papers by Christel Jublanc in
Google Scholar
PubMed
Université Paris Cité, Inserm, PARCC, Paris, France
Search for other papers by Nelly Burnichon in
Google Scholar
PubMed
Université Paris Cité, Inserm, PARCC, Paris, France
Search for other papers by Laurence Amar in
Google Scholar
PubMed
Search for other papers by Judith Favier in
Google Scholar
PubMed
Université Paris Cité, Inserm, PARCC, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Université Paris Cité, Inserm, PARCC, Paris, France
Search for other papers by Alexandre Buffet in
Google Scholar
PubMed
Paris Cardiovascular Research Center (PARCC), Inserm, Paris, France
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
neuroendocrine tumours . Endocrine-Related Cancer 29 R157 – R172 . ( https://doi.org/10.1530/ERC-22-0157 ) Lussey-Lepoutre C Bellucci A Burnichon N Amar L Buffet A Drossart T Fontaine S Clement O Benit P Rustin P 2020 Succinate detection
Search for other papers by Audrey Ziverec in
Google Scholar
PubMed
Search for other papers by Marie Chanal in
Google Scholar
PubMed
Search for other papers by Perrine Raymond in
Google Scholar
PubMed
Endocrinology Department, “C.I. Parhon” National Institute of Endocrinology, Bucharest, Romania
Search for other papers by Mirela Diana Ilie in
Google Scholar
PubMed
Search for other papers by Dario De Alcubierre in
Google Scholar
PubMed
Search for other papers by Arja Pasternack in
Google Scholar
PubMed
Search for other papers by Olli Ritvos in
Google Scholar
PubMed
Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France
Department of Endocrinology, Reference center for rare pituitary disease (HYPO), Groupement Hospitalier EST, Hospices Civils de Lyon, University of Lyon, Lyon, France
Search for other papers by Gerald Raverot in
Google Scholar
PubMed
Search for other papers by Philippe Bertolino in
Google Scholar
PubMed
microenvironment in pituitary neuroendocrine tumours . Acta Neuropathologica Communications 7 172. ( https://doi.org/10.1186/s40478-019-0830-3 ) Marques P Barry S Carlsen E Collier D Ronaldson A Dorward N Grieve J Mendoza N Nair R Muquit S